# Evista

NDC: 0002-4184
Generic name: Raloxifene hydrochloride
Labeler / Manufacturer: Eli Lilly and Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 19980106

FDA application: NDA020815

## Active ingredients

- RALOXIFENE HYDROCHLORIDE: 60 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0002-4184"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0002-4184
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9